Digital Tools for Chronic Disease Management Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Deployment, End User, Solutions, Mode

Description

The global Digital Tools for Chronic Disease Management Market is projected to grow from $13.4 billion in 2025 to $39.4 billion by 2035, at a compound annual growth rate (CAGR) of 11.4%. The market is supported by a broad global shift toward digitally enabled chronic-care delivery rather than isolated technology adoption. WHO reported in 2025 that 129 countries had established national digital health strategies, demonstrating substantial institutional commitment to digital transformation. More than 1,600 government officials from over 100 countries had also received digital health and artificial intelligence training, while digital health certification initiatives had reached approximately 1.8 billion people across 80 countries. WHO further identifies interoperability, data sharing, infrastructure, privacy, and affordability as important foundations for sustainable digital health deployment. These developments indicate expanding demand for connected monitoring, analytics, and patient-engagement technologies.

The product segment encompasses glucose monitoring devices, blood pressure monitors, heart rate monitors, medication adherence tools, diet and nutrition trackers, and fitness trackers. These solutions capture physiological, behavioral, and lifestyle data through sensors, connected devices, mobile applications, and automated reminders. Glucose and blood-pressure monitoring support disease-specific control, while adherence, nutrition, and fitness tools reinforce patient self-management. Integration with clinical platforms enables longitudinal monitoring and earlier intervention. Demand is shifting toward interoperable, wearable, and continuously connected products capable of generating actionable patient insights. Product adoption is expected to expand as healthcare providers increasingly incorporate remote monitoring and digitally enabled chronic-care pathways.

Market Segmentation
Type	Mobile Apps, Web-based Platforms, Wearable Devices, Telehealth Solutions, Remote Monitoring Systems, Others
Product	Blood Glucose Monitors, Blood Pressure Monitors, Smart Insulin Pens, Connected Inhalers, Smart Patches, Others
Services	Patient Education, Remote Consultation, Medication Management, Lifestyle Coaching, Data Analytics, Others
Technology	AI and Machine Learning, Blockchain, IoT, Cloud Computing, Big Data Analytics, Others
Component	Software, Hardware, Services, Others
Application	Diabetes Management, Cardiovascular Disease Management, Respiratory Disease Management, Cancer Management, Mental Health Management, Others
Deployment	On-premise, Cloud-based, Hybrid, Others
End User	Hospitals, Clinics, Homecare Settings, Research Institutes, Others
Solutions	Chronic Care Management, Patient Engagement Solutions, Care Coordination, Population Health Management, Others
Mode	Self-management, Professional Management, Others

The technology segment includes artificial intelligence, machine learning, blockchain, cloud computing, Internet of Things (IoT), and big data analytics. AI and machine learning enable risk prediction, personalized recommendations, anomaly detection, and clinical decision support, while IoT connects monitoring devices with healthcare ecosystems for continuous data transmission. Cloud computing provides scalable infrastructure for storing and processing longitudinal health information, whereas blockchain can strengthen data integrity and controlled information exchange. Big data analytics supports population-risk stratification and treatment optimization. Technology convergence is accelerating as healthcare systems pursue interoperable, secure, data-driven chronic disease management models aligned with national digital health strategies.

Geographical Overview

North America maintains a substantial market position due to advanced healthcare infrastructure, high adoption of connected medical devices, established electronic health-record ecosystems, and strong demand for remote chronic-care management. The region benefits from extensive provider networks, technology investment, digital therapeutics development, and reimbursement mechanisms supporting remote monitoring. The United States represents the principal demand base, with healthcare organizations increasingly integrating digital tools into cardiovascular, metabolic, behavioral, and other chronic disease pathways. Regulatory activity is also supporting innovation; the U.S. FDA launched its TEMPO pilot in 2025 to facilitate access to selected digital health devices addressing chronic conditions while applying a risk-based approach to patient safety.

Asia Pacific presents considerable expansion potential as governments strengthen digital health infrastructure, smartphone connectivity, cloud capabilities, and technology-enabled healthcare delivery. Countries including China, Japan, South Korea, India, Singapore, and Australia are increasing investments in health information systems, remote monitoring, artificial intelligence, and connected care platforms. Rising chronic disease prevalence, expanding healthcare expenditure, and large patient populations are encouraging providers to adopt scalable digital management solutions. Government-led digital transformation programs and national health strategies are improving interoperability and technology readiness, while partnerships among healthcare providers, technology companies, and device manufacturers are accelerating commercialization. Continued infrastructure development and broader digital-health integration are expected to strengthen regional demand over the coming years.

Key Trends and Drivers

Connected Care Redefining Chronic Disease Management:

The market is moving toward integrated, continuously connected chronic-care ecosystems that combine wearable monitoring, mobile applications, artificial intelligence, and cloud-based analytics. Rather than relying on periodic clinical measurements, providers increasingly seek longitudinal patient data that can identify deterioration, personalize interventions, and support proactive care. Interoperability is becoming particularly important as health systems connect devices, electronic records, analytics platforms, and patient-facing applications. The increasing emphasis on person-centered digital health is also encouraging solutions that combine clinical monitoring with behavioral, nutritional, and medication-management capabilities.

Rising Chronic Disease Burden Accelerating Digital Care Adoption:

The growing burden of chronic conditions is increasing demand for scalable and continuous disease-management models that extend care beyond traditional clinical settings. Digital tools enable remote monitoring, automated communication, medication reminders, lifestyle tracking, and data-supported clinical intervention while reducing dependence on frequent in-person encounters. Healthcare providers can use digitally generated information to identify high-risk patients and prioritize interventions, while patients gain greater visibility into their health status and treatment adherence. Government support for digital transformation is reinforcing this demand, with WHO promoting digital technologies that improve health-system efficiency, disease management, accessibility, and continuity of care.

Research Scope

Estimates and forecasts the overall market size across type, application, and region.
Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

Product Code: GIS32865

1 Executive Summary

1.1 Market Size and Forecast
1.2 Market Overview
1.3 Market Snapshot
1.4 Regional Snapshot
1.5 Strategic Recommendations
1.6 Analyst Notes

2 Market Highlights

2.1 Key Market Highlights by Type
2.2 Key Market Highlights by Product
2.3 Key Market Highlights by Services
2.4 Key Market Highlights by Technology
2.5 Key Market Highlights by Component
2.6 Key Market Highlights by Application
2.7 Key Market Highlights by Deployment
2.8 Key Market Highlights by End User
2.9 Key Market Highlights by Solutions
2.10 Key Market Highlights by Mode

3 Market Dynamics

3.1 Macroeconomic Analysis
3.2 Market Trends
3.3 Market Drivers
3.4 Market Opportunities
3.5 Market Restraints
3.6 CAGR Growth Analysis
3.7 Impact Analysis
3.8 Emerging Markets
3.9 Technology Roadmap
3.10 Strategic Frameworks
- 3.10.1 PORTER's 5 Forces Model
- 3.10.2 ANSOFF Matrix
- 3.10.3 4P's Model
- 3.10.4 PESTEL Analysis

4 Segment Analysis

4.1 Market Size & Forecast by Type (2020-2035)
- 4.1.1 Mobile Apps
- 4.1.2 Web-based Platforms
- 4.1.3 Wearable Devices
- 4.1.4 Telehealth Solutions
- 4.1.5 Remote Monitoring Systems
- 4.1.6 Others
4.2 Market Size & Forecast by Product (2020-2035)
- 4.2.1 Blood Glucose Monitors
- 4.2.2 Blood Pressure Monitors
- 4.2.3 Smart Insulin Pens
- 4.2.4 Connected Inhalers
- 4.2.5 Smart Patches
- 4.2.6 Others
4.3 Market Size & Forecast by Services (2020-2035)
- 4.3.1 Patient Education
- 4.3.2 Remote Consultation
- 4.3.3 Medication Management
- 4.3.4 Lifestyle Coaching
- 4.3.5 Data Analytics
- 4.3.6 Others
4.4 Market Size & Forecast by Technology (2020-2035)
- 4.4.1 AI and Machine Learning
- 4.4.2 Blockchain
- 4.4.3 IoT
- 4.4.4 Cloud Computing
- 4.4.5 Big Data Analytics
- 4.4.6 Others
4.5 Market Size & Forecast by Component (2020-2035)
- 4.5.1 Software
- 4.5.2 Hardware
- 4.5.3 Services
- 4.5.4 Others
4.6 Market Size & Forecast by Application (2020-2035)
- 4.6.1 Diabetes Management
- 4.6.2 Cardiovascular Disease Management
- 4.6.3 Respiratory Disease Management
- 4.6.4 Cancer Management
- 4.6.5 Mental Health Management
- 4.6.6 Others
4.7 Market Size & Forecast by Deployment (2020-2035)
- 4.7.1 On-premise
- 4.7.2 Cloud-based
- 4.7.3 Hybrid
- 4.7.4 Others
4.8 Market Size & Forecast by End User (2020-2035)
- 4.8.1 Hospitals
- 4.8.2 Clinics
- 4.8.3 Homecare Settings
- 4.8.4 Research Institutes
- 4.8.5 Others
4.9 Market Size & Forecast by Solutions (2020-2035)
- 4.9.1 Chronic Care Management
- 4.9.2 Patient Engagement Solutions
- 4.9.3 Care Coordination
- 4.9.4 Population Health Management
- 4.9.5 Others
4.10 Market Size & Forecast by Mode (2020-2035)
- 4.10.1 Self-management
- 4.10.2 Professional Management
- 4.10.3 Others

5 Regional Analysis

5.1 Global Market Overview
5.2 North America Market Size (2020-2035)
- 5.2.1 United States
  - 5.2.1.1 Type
  - 5.2.1.2 Product
  - 5.2.1.3 Services
  - 5.2.1.4 Technology
  - 5.2.1.5 Component
  - 5.2.1.6 Application
  - 5.2.1.7 Deployment
  - 5.2.1.8 End User
  - 5.2.1.9 Solutions
  - 5.2.1.10 Mode
- 5.2.2 Canada
  - 5.2.2.1 Type
  - 5.2.2.2 Product
  - 5.2.2.3 Services
  - 5.2.2.4 Technology
  - 5.2.2.5 Component
  - 5.2.2.6 Application
  - 5.2.2.7 Deployment
  - 5.2.2.8 End User
  - 5.2.2.9 Solutions
  - 5.2.2.10 Mode
- 5.2.3 Mexico
  - 5.2.3.1 Type
  - 5.2.3.2 Product
  - 5.2.3.3 Services
  - 5.2.3.4 Technology
  - 5.2.3.5 Component
  - 5.2.3.6 Application
  - 5.2.3.7 Deployment
  - 5.2.3.8 End User
  - 5.2.3.9 Solutions
  - 5.2.3.10 Mode
5.3 Latin America Market Size (2020-2035)
- 5.3.1 Brazil
  - 5.3.1.1 Type
  - 5.3.1.2 Product
  - 5.3.1.3 Services
  - 5.3.1.4 Technology
  - 5.3.1.5 Component
  - 5.3.1.6 Application
  - 5.3.1.7 Deployment
  - 5.3.1.8 End User
  - 5.3.1.9 Solutions
  - 5.3.1.10 Mode
- 5.3.2 Argentina
  - 5.3.2.1 Type
  - 5.3.2.2 Product
  - 5.3.2.3 Services
  - 5.3.2.4 Technology
  - 5.3.2.5 Component
  - 5.3.2.6 Application
  - 5.3.2.7 Deployment
  - 5.3.2.8 End User
  - 5.3.2.9 Solutions
  - 5.3.2.10 Mode
- 5.3.3 Rest of Latin America
  - 5.3.3.1 Type
  - 5.3.3.2 Product
  - 5.3.3.3 Services
  - 5.3.3.4 Technology
  - 5.3.3.5 Component
  - 5.3.3.6 Application
  - 5.3.3.7 Deployment
  - 5.3.3.8 End User
  - 5.3.3.9 Solutions
  - 5.3.3.10 Mode
5.4 Asia-Pacific Market Size (2020-2035)
- 5.4.1 China
  - 5.4.1.1 Type
  - 5.4.1.2 Product
  - 5.4.1.3 Services
  - 5.4.1.4 Technology
  - 5.4.1.5 Component
  - 5.4.1.6 Application
  - 5.4.1.7 Deployment
  - 5.4.1.8 End User
  - 5.4.1.9 Solutions
  - 5.4.1.10 Mode
- 5.4.2 India
  - 5.4.2.1 Type
  - 5.4.2.2 Product
  - 5.4.2.3 Services
  - 5.4.2.4 Technology
  - 5.4.2.5 Component
  - 5.4.2.6 Application
  - 5.4.2.7 Deployment
  - 5.4.2.8 End User
  - 5.4.2.9 Solutions
  - 5.4.2.10 Mode
- 5.4.3 South Korea
  - 5.4.3.1 Type
  - 5.4.3.2 Product
  - 5.4.3.3 Services
  - 5.4.3.4 Technology
  - 5.4.3.5 Component
  - 5.4.3.6 Application
  - 5.4.3.7 Deployment
  - 5.4.3.8 End User
  - 5.4.3.9 Solutions
  - 5.4.3.10 Mode
- 5.4.4 Japan
  - 5.4.4.1 Type
  - 5.4.4.2 Product
  - 5.4.4.3 Services
  - 5.4.4.4 Technology
  - 5.4.4.5 Component
  - 5.4.4.6 Application
  - 5.4.4.7 Deployment
  - 5.4.4.8 End User
  - 5.4.4.9 Solutions
  - 5.4.4.10 Mode
- 5.4.5 Australia
  - 5.4.5.1 Type
  - 5.4.5.2 Product
  - 5.4.5.3 Services
  - 5.4.5.4 Technology
  - 5.4.5.5 Component
  - 5.4.5.6 Application
  - 5.4.5.7 Deployment
  - 5.4.5.8 End User
  - 5.4.5.9 Solutions
  - 5.4.5.10 Mode
- 5.4.6 Taiwan
  - 5.4.6.1 Type
  - 5.4.6.2 Product
  - 5.4.6.3 Services
  - 5.4.6.4 Technology
  - 5.4.6.5 Component
  - 5.4.6.6 Application
  - 5.4.6.7 Deployment
  - 5.4.6.8 End User
  - 5.4.6.9 Solutions
  - 5.4.6.10 Mode
- 5.4.7 Rest of APAC
  - 5.4.7.1 Type
  - 5.4.7.2 Product
  - 5.4.7.3 Services
  - 5.4.7.4 Technology
  - 5.4.7.5 Component
  - 5.4.7.6 Application
  - 5.4.7.7 Deployment
  - 5.4.7.8 End User
  - 5.4.7.9 Solutions
  - 5.4.7.10 Mode
5.5 Europe Market Size (2020-2035)
- 5.5.1 Germany
  - 5.5.1.1 Type
  - 5.5.1.2 Product
  - 5.5.1.3 Services
  - 5.5.1.4 Technology
  - 5.5.1.5 Component
  - 5.5.1.6 Application
  - 5.5.1.7 Deployment
  - 5.5.1.8 End User
  - 5.5.1.9 Solutions
  - 5.5.1.10 Mode
- 5.5.2 France
  - 5.5.2.1 Type
  - 5.5.2.2 Product
  - 5.5.2.3 Services
  - 5.5.2.4 Technology
  - 5.5.2.5 Component
  - 5.5.2.6 Application
  - 5.5.2.7 Deployment
  - 5.5.2.8 End User
  - 5.5.2.9 Solutions
  - 5.5.2.10 Mode
- 5.5.3 United Kingdom
  - 5.5.3.1 Type
  - 5.5.3.2 Product
  - 5.5.3.3 Services
  - 5.5.3.4 Technology
  - 5.5.3.5 Component
  - 5.5.3.6 Application
  - 5.5.3.7 Deployment
  - 5.5.3.8 End User
  - 5.5.3.9 Solutions
  - 5.5.3.10 Mode
- 5.5.4 Spain
  - 5.5.4.1 Type
  - 5.5.4.2 Product
  - 5.5.4.3 Services
  - 5.5.4.4 Technology
  - 5.5.4.5 Component
  - 5.5.4.6 Application
  - 5.5.4.7 Deployment
  - 5.5.4.8 End User
  - 5.5.4.9 Solutions
  - 5.5.4.10 Mode
- 5.5.5 Italy
  - 5.5.5.1 Type
  - 5.5.5.2 Product
  - 5.5.5.3 Services
  - 5.5.5.4 Technology
  - 5.5.5.5 Component
  - 5.5.5.6 Application
  - 5.5.5.7 Deployment
  - 5.5.5.8 End User
  - 5.5.5.9 Solutions
  - 5.5.5.10 Mode
- 5.5.6 Rest of Europe
  - 5.5.6.1 Type
  - 5.5.6.2 Product
  - 5.5.6.3 Services
  - 5.5.6.4 Technology
  - 5.5.6.5 Component
  - 5.5.6.6 Application
  - 5.5.6.7 Deployment
  - 5.5.6.8 End User
  - 5.5.6.9 Solutions
  - 5.5.6.10 Mode
5.6 Middle East & Africa Market Size (2020-2035)
- 5.6.1 Saudi Arabia
  - 5.6.1.1 Type
  - 5.6.1.2 Product
  - 5.6.1.3 Services
  - 5.6.1.4 Technology
  - 5.6.1.5 Component
  - 5.6.1.6 Application
  - 5.6.1.7 Deployment
  - 5.6.1.8 End User
  - 5.6.1.9 Solutions
  - 5.6.1.10 Mode
- 5.6.2 United Arab Emirates
  - 5.6.2.1 Type
  - 5.6.2.2 Product
  - 5.6.2.3 Services
  - 5.6.2.4 Technology
  - 5.6.2.5 Component
  - 5.6.2.6 Application
  - 5.6.2.7 Deployment
  - 5.6.2.8 End User
  - 5.6.2.9 Solutions
  - 5.6.2.10 Mode
- 5.6.3 South Africa
  - 5.6.3.1 Type
  - 5.6.3.2 Product
  - 5.6.3.3 Services
  - 5.6.3.4 Technology
  - 5.6.3.5 Component
  - 5.6.3.6 Application
  - 5.6.3.7 Deployment
  - 5.6.3.8 End User
  - 5.6.3.9 Solutions
  - 5.6.3.10 Mode
- 5.6.4 Sub-Saharan Africa
  - 5.6.4.1 Type
  - 5.6.4.2 Product
  - 5.6.4.3 Services
  - 5.6.4.4 Technology
  - 5.6.4.5 Component
  - 5.6.4.6 Application
  - 5.6.4.7 Deployment
  - 5.6.4.8 End User
  - 5.6.4.9 Solutions
  - 5.6.4.10 Mode
- 5.6.5 Rest of MEA
  - 5.6.5.1 Type
  - 5.6.5.2 Product
  - 5.6.5.3 Services
  - 5.6.5.4 Technology
  - 5.6.5.5 Component
  - 5.6.5.6 Application
  - 5.6.5.7 Deployment
  - 5.6.5.8 End User
  - 5.6.5.9 Solutions
  - 5.6.5.10 Mode

6 Market Strategy

6.1 Demand-Supply Gap Analysis
6.2 Trade & Logistics Constraints
6.3 Price-Cost-Margin Trends
6.4 Market Penetration
6.5 Consumer Analysis
6.6 Regulatory Snapshot

7 Competitive Intelligence

7.1 Market Positioning
7.2 Market Share
7.3 Competition Benchmarking
7.4 Top Company Strategies

8 Company Profiles

8.1 Medtronic
- 8.1.1 Overview
- 8.1.2 Product Summary
- 8.1.3 Financial Performance
- 8.1.4 SWOT Analysis
8.2 Philips Healthcare
- 8.2.1 Overview
- 8.2.2 Product Summary
- 8.2.3 Financial Performance
- 8.2.4 SWOT Analysis
8.3 Roche
- 8.3.1 Overview
- 8.3.2 Product Summary
- 8.3.3 Financial Performance
- 8.3.4 SWOT Analysis
8.4 Abbott Laboratories
- 8.4.1 Overview
- 8.4.2 Product Summary
- 8.4.3 Financial Performance
- 8.4.4 SWOT Analysis
8.5 Johnson and Johnson
- 8.5.1 Overview
- 8.5.2 Product Summary
- 8.5.3 Financial Performance
- 8.5.4 SWOT Analysis
8.6 Dexcom
- 8.6.1 Overview
- 8.6.2 Product Summary
- 8.6.3 Financial Performance
- 8.6.4 SWOT Analysis
8.7 Omron Healthcare
- 8.7.1 Overview
- 8.7.2 Product Summary
- 8.7.3 Financial Performance
- 8.7.4 SWOT Analysis
8.8 ResMed
- 8.8.1 Overview
- 8.8.2 Product Summary
- 8.8.3 Financial Performance
- 8.8.4 SWOT Analysis
8.9 GE Healthcare
- 8.9.1 Overview
- 8.9.2 Product Summary
- 8.9.3 Financial Performance
- 8.9.4 SWOT Analysis
8.10 Siemens Healthineers
- 8.10.1 Overview
- 8.10.2 Product Summary
- 8.10.3 Financial Performance
- 8.10.4 SWOT Analysis
8.11 Bayer
- 8.11.1 Overview
- 8.11.2 Product Summary
- 8.11.3 Financial Performance
- 8.11.4 SWOT Analysis
8.12 Sanofi
- 8.12.1 Overview
- 8.12.2 Product Summary
- 8.12.3 Financial Performance
- 8.12.4 SWOT Analysis
8.13 Novo Nordisk
- 8.13.1 Overview
- 8.13.2 Product Summary
- 8.13.3 Financial Performance
- 8.13.4 SWOT Analysis
8.14 AstraZeneca
- 8.14.1 Overview
- 8.14.2 Product Summary
- 8.14.3 Financial Performance
- 8.14.4 SWOT Analysis
8.15 GlaxoSmithKline
- 8.15.1 Overview
- 8.15.2 Product Summary
- 8.15.3 Financial Performance
- 8.15.4 SWOT Analysis
8.16 Boehringer Ingelheim
- 8.16.1 Overview
- 8.16.2 Product Summary
- 8.16.3 Financial Performance
- 8.16.4 SWOT Analysis
8.17 Tandem Diabetes Care
- 8.17.1 Overview
- 8.17.2 Product Summary
- 8.17.3 Financial Performance
- 8.17.4 SWOT Analysis
8.18 Insulet Corporation
- 8.18.1 Overview
- 8.18.2 Product Summary
- 8.18.3 Financial Performance
- 8.18.4 SWOT Analysis
8.19 Livongo Health
- 8.19.1 Overview
- 8.19.2 Product Summary
- 8.19.3 Financial Performance
- 8.19.4 SWOT Analysis
8.20 WellDoc
- 8.20.1 Overview
- 8.20.2 Product Summary
- 8.20.3 Financial Performance
- 8.20.4 SWOT Analysis

9 About Us

9.1 About Us
9.2 Research Methodology
9.3 Research Workflow
9.4 Consulting Services
9.5 Our Clients
9.6 Client Testimonials
9.7 Contact Us